Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — XZO

Balance Sheet

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025
Cash & Equivalents	136.73	231.38	305.37	140.92
Accounts Receivable	1.79	2.51	2.91	--
Total Current Assets	169.70	260.93	325.82	162.65
Property, Plant & Equipment	9.73	10.26	10.66	10.85
Total Non-current Assets	216.08	118.84	21.91	19.61
Total Assets	385.78	379.77	347.73	182.25
Accounts Payable	8.36	6.17	2.95	11.65
Total Current Liabilities	91.74	98.58	84.39	93.93
Total Non-current Liabilities	5.88	6.25	9.19	9.90
Total Liabilities	97.61	104.83	93.58	103.82
Retained Earnings	69.09	45.82	25.42	3.43
Total Stockholder Equity	288.17	274.94	254.16	78.43

← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025
Total Revenue	57.79	55.53	53.32	55.17
Cost of Revenue	20.95	22.79	18.44	21.39
Gross Profit	36.84	32.74	34.87	33.77
Research & Development	2.44	2.31	1.76	2.49
Selling, General & Admin	5.79	5.22	6.16	3.90
Total Operating Expenses	8.38	7.67	8.06	6.52
Operating Income	28.46	25.08	26.81	27.25
Pretax Income	31.43	27.59	28.85	28.35
Tax Provision	8.16	7.18	6.87	7.20
Net Income	23.27	20.41	21.98	21.15
Basic EPS	0.26	0.22	0.26	0.25
Diluted EPS	0.26	0.22	0.26	0.25

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025
Operating Cash Flow	15.42	25.47	--	89.02
Capital Expenditures	0.21	0.33	--	2.44
Free Cash Flow*	15.21	25.15	--	86.58
Investing Cash Flow	(99.61)	(99.32)	--	--
Financing Cash Flow	(10.36)	(0.06)	153.65	0.00

← Scroll for more columns →

* Derived from reported values